Indolderivater, der er nyttige som histamin H3-antagonister

Disclosed are novel compounds of the formula I wherein M 1 is CH or N and M 2 is C(R 3 ) or N; R 1 is optionally substituted indolyl or an aza derivative thereof; R 2 is optionally substituted aryl or heteroaryl; and the remaining variables are as defined in the specification. Also discl 1 receptor...

Full description

Saved in:
Bibliographic Details
Main Authors MUTAHI, MWANGI, W, MANGIARACINA, PIETRO, MCCORMICK, KEVIN, D, ROSENBLUM, STUART, B, ASLANIAN, ROBERT, G, BERLIN, MICHAEL, Y
Format Patent
LanguageDanish
Published 27.12.2006
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Disclosed are novel compounds of the formula I wherein M 1 is CH or N and M 2 is C(R 3 ) or N; R 1 is optionally substituted indolyl or an aza derivative thereof; R 2 is optionally substituted aryl or heteroaryl; and the remaining variables are as defined in the specification. Also discl 1 receptor antagonist for treating various diseases or conditions, such as, for example, allergy, allergy-i
Bibliography:Application Number: DK20030761216T